TTC29

Across TCGA pan-cancer cohorts, TTC29 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated TTC29 data layer compared with 8 for mutation status and 1 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher TTC29 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TTC29 expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCS show a favorable association.

STAD, BRCA, and THCA are the cancer types where TTC29 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Quartile	All	0.583	0.754	<.001	74	view →
BRCA	DFS	Tertile	All	0.664	0.458	.001	53	view →
THCA	OS	Median	II,III,IV	0.927	1.000	.008	32	view →
KIRP	OS	Quartile	All	0.854	0.972	.002	16	view →
LUAD	DFS	Quartile	IV	0.262	0.769	.010	12	view →
UCS	OS	Median	IV	0.693	0.262	.047	6	view →
CESC	OS	Tertile	All	0.917	0.839	.035	6	view →
HNSC	OS	Median	IV	0.755	0.508	.008	6	view →
SARC	OS	Median	All	0.686	0.795	.009	5	view →
PRAD	DFS	Tertile	All	0.854	0.918	.042	4	view →
SCLC	DFS	Median	All	0.351	0.150	.017	3	view →
KICH	DFS	Median	IV	0.923	0.317	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

TTC29–STAD (OS)

Open the STAD breakdown →